Mirae Asset Sharekhan Recommends Aurobindo Pharma and IRCTC Stocks for Potential Growth to Rs 1356 and Rs 802.

Stock market experts at Mirae Asset Sharekhan have recommended two strong buy options for investors in India. One of their top picks is Aurobindo Pharma, where they foresee a breakout from a flag pattern. The target price set for Aurobindo Pharma is Rs 1356, indicating a potential upward movement. Another promising recommendation from Mirae Asset Sharekhan is IRCTC, with expectations of an upward trend to Rs 802 after breaking consolidation. These recommendations come at a time when investors are keen on identifying lucrative opportunities in the stock market. Aurobindo Pharma and IRCTC are both prominent players in their respective sectors, making them attractive options for investors looking to diversify their portfolios. With the ongoing volatility in the market, expert recommendations such as these can provide valuable insights for investors seeking profitable trades. It is advisable for investors to conduct thorough research and consult with financial advisors before making any investment decisions.

In Trend

Vitalik Buterin Discusses Rollup Decentralization Timing; Security Must Prevail Over Speed, Experts Warn.

“Indian stock market opens flat: Nifty50 near 24,450, BSE Sensex above 80,700 on Tuesday trading”

Leave a Reply

Your email address will not be published. Required fields are marked *